These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16252275)

  • 1. A mixed effects Markov model for repeated binary outcomes with non-ignorable dropout.
    Gallop RJ; Ten Have TR; Crits-Christoph P
    Stat Med; 2006 Jul; 25(14):2398-426. PubMed ID: 16252275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mixed model for two-state Markov processes under panel observation.
    Cook RJ
    Biometrics; 1999 Sep; 55(3):915-20. PubMed ID: 11315028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markov transition models for binary repeated measures with ignorable and nonignorable missing values.
    Xiaowei Yang ; Shoptaw S; Kun Nie ; Juanmei Liu ; Belin TR
    Stat Methods Med Res; 2007 Aug; 16(4):347-64. PubMed ID: 17715161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
    Li J; Yang X; Wu Y; Shoptaw S
    Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A shared-parameter continuous-time hidden Markov and survival model for longitudinal data with informative dropout.
    Bartolucci F; Farcomeni A
    Stat Med; 2019 Mar; 38(6):1056-1073. PubMed ID: 30324662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian latent-class mixed-effect hybrid models for dyadic longitudinal data with non-ignorable dropouts.
    Ahn J; Liu S; Wang W; Yuan Y
    Biometrics; 2013 Dec; 69(4):914-24. PubMed ID: 24328715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An index of local sensitivity to non-ignorability for multivariate longitudinal mixed data with potential non-random dropout.
    Mahabadi SE; Ganjali M
    Stat Med; 2010 Jul; 29(17):1779-92. PubMed ID: 20658547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden Markov latent variable models with multivariate longitudinal data.
    Song X; Xia Y; Zhu H
    Biometrics; 2017 Mar; 73(1):313-323. PubMed ID: 27148857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transition model for ordinal response data with random dropout: an application to the fluvoxamine data.
    Ghahroodi ZR; Ganjali M; Berridge D
    J Biopharm Stat; 2009 Jul; 19(4):658-71. PubMed ID: 20183432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-state Markov models for disease progression in the presence of informative examination times: an application to hepatitis C.
    Sweeting MJ; Farewell VT; De Angelis D
    Stat Med; 2010 May; 29(11):1161-74. PubMed ID: 20437454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data.
    Albert PS; Follmann DA
    Stat Methods Med Res; 2007 Oct; 16(5):417-39. PubMed ID: 17656452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transition model for quality-of-life data with non-ignorable non-monotone missing data.
    Liao K; Freres DR; Troxel AB
    Stat Med; 2012 Dec; 31(28):3444-66. PubMed ID: 22826030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-out.
    Kurland BF; Heagerty PJ
    Stat Med; 2004 Sep; 23(17):2673-95. PubMed ID: 15316952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous time Markov models for binary longitudinal data.
    Jones RH; Xu S; Grunwald GK
    Biom J; 2006 Jun; 48(3):411-9. PubMed ID: 16845905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-Markov Arnason-Schwarz models.
    King R; Langrock R
    Biometrics; 2016 Jun; 72(2):619-28. PubMed ID: 26584064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple imputation under Bayesianly smoothed pattern-mixture models for non-ignorable drop-out.
    Demirtas H
    Stat Med; 2005 Aug; 24(15):2345-63. PubMed ID: 15977286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mixed effects model for the analysis of ordinal longitudinal pain data subject to informative drop-out.
    Pulkstenis E; Ten Have TR; Landis JR
    Stat Med; 2001 Feb; 20(4):601-22. PubMed ID: 11223903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.
    Lalovic B; Hutmacher M; Frame B; Miller R
    J Clin Pharmacol; 2011 May; 51(5):706-18. PubMed ID: 20663989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
    Cole BF; Bonetti M; Zaslavsky AM; Gelber RD
    Stat Med; 2005 Aug; 24(15):2317-34. PubMed ID: 15977292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A local sensitivity analysis approach to longitudinal non-Gaussian data with non-ignorable dropout.
    Xie H
    Stat Med; 2008 Jul; 27(16):3155-77. PubMed ID: 17948917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.